RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보

      정신분열병 환자에서 Clozapine에 의한 체중 증가와 Serotonin 5-HT2C 수용체 유전자 -759C/T 다형성과의 연관성 = Association between Clozapine-InducedWeight Gain and Serotonin 5-HT2C ReceptorGene Polymorphism in Patients with Schizophrenia

      한글로보기

      https://www.riss.kr/link?id=A104600838

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      Objective: Weight gain is one of the troublesome adverse reaction to clozapine treatment. This problem can lead to poor adherence to treatment. Clozapine-induced weight gain may be associated with genetic predisposition. Recent studies have shown that a polymorphism of the promoter region of the serotonin 5-HT2C receptor gene is associated with antipsychotic-induced weight gain. This study is to investigate the association of clozapine-induced weight gain with -759C/T polymorphism of serotonin 5-HT2C receptor promoter gene in schizophrenic patients. Methods: Fifty three patients with schizophrenia were included in this study. The subjects were divided into two groups according to body weight change between the start and 10 weeks of clozapine. The cutoff level of weight change is 5% increase of initial body weight. Genotypes of -759C/T polymorphism were identified from AciI-digested fragments of two-primer products amplified by polymerase chain reaction corresponding to -885 to -634 of the serotonin 5-HT2C receptor gene promoter region on chromosome X. Results: There were no differences of baseline variables between patient groups with and without weight gain. 4 of 32 male patients and 6 of 21 female patients had -759T allele, respectively. The authors found that patients with -759T allele had tendency to show less weight gain than those without this allele. Conclusions: These findings suggest that clozapine-induced weight gain may be associated with genetic predisposition in schizophrenic patients.
      번역하기

      Objective: Weight gain is one of the troublesome adverse reaction to clozapine treatment. This problem can lead to poor adherence to treatment. Clozapine-induced weight gain may be associated with genetic predisposition. Recent studies have shown that...

      Objective: Weight gain is one of the troublesome adverse reaction to clozapine treatment. This problem can lead to poor adherence to treatment. Clozapine-induced weight gain may be associated with genetic predisposition. Recent studies have shown that a polymorphism of the promoter region of the serotonin 5-HT2C receptor gene is associated with antipsychotic-induced weight gain. This study is to investigate the association of clozapine-induced weight gain with -759C/T polymorphism of serotonin 5-HT2C receptor promoter gene in schizophrenic patients. Methods: Fifty three patients with schizophrenia were included in this study. The subjects were divided into two groups according to body weight change between the start and 10 weeks of clozapine. The cutoff level of weight change is 5% increase of initial body weight. Genotypes of -759C/T polymorphism were identified from AciI-digested fragments of two-primer products amplified by polymerase chain reaction corresponding to -885 to -634 of the serotonin 5-HT2C receptor gene promoter region on chromosome X. Results: There were no differences of baseline variables between patient groups with and without weight gain. 4 of 32 male patients and 6 of 21 female patients had -759T allele, respectively. The authors found that patients with -759T allele had tendency to show less weight gain than those without this allele. Conclusions: These findings suggest that clozapine-induced weight gain may be associated with genetic predisposition in schizophrenic patients.

      더보기

      참고문헌 (Reference)

      1 "Treatment of the metabolic disturbances caused by antipsychotic drugs:Focus on potential drug interactions" 43 : 1-15, 2004

      2 "The search for human obesity genes" 280 : 1374-1378, 1998

      3 "The Pharmacology of weight gain with an-tipsychotics" 62 (62): 4-10, 2001

      4 "Serotonin receptor 1c gene assigned to X chromosome in human" 681-684,

      5 "Reducing the risk for suicide in schizophrenia and affective disorders" 64 : 1122-1129, 2003

      6 "Polymorphism of the pro-moter region of the serotonin 5-HT2C receptor gene and cloza-pine-induced weight gain" 60 : 677-679, 2003

      7 "Physical consequences of schizophrenia and its treatment:The metabolic syndrome" 71 : 239-257, 2001

      8 "Identification, expresion, and pharmacology of a Cys23-Ser23 sub-stitutiom in the human 5-HT2C receptor gene(HTR2C)" 27 : 274-279, 1995

      9 "Identification of polymorphic loci in the promoter re-gion of the serotonin 5-HT2C receptor gene and their asociation with obesity and type I diabetes" 43 : 373-376, 2000

      10 "Genetic variants of the serotonin system and weight change during clozapine treat-ment" 11 : 265-268, 2001

      1 "Treatment of the metabolic disturbances caused by antipsychotic drugs:Focus on potential drug interactions" 43 : 1-15, 2004

      2 "The search for human obesity genes" 280 : 1374-1378, 1998

      3 "The Pharmacology of weight gain with an-tipsychotics" 62 (62): 4-10, 2001

      4 "Serotonin receptor 1c gene assigned to X chromosome in human" 681-684,

      5 "Reducing the risk for suicide in schizophrenia and affective disorders" 64 : 1122-1129, 2003

      6 "Polymorphism of the pro-moter region of the serotonin 5-HT2C receptor gene and cloza-pine-induced weight gain" 60 : 677-679, 2003

      7 "Physical consequences of schizophrenia and its treatment:The metabolic syndrome" 71 : 239-257, 2001

      8 "Identification, expresion, and pharmacology of a Cys23-Ser23 sub-stitutiom in the human 5-HT2C receptor gene(HTR2C)" 27 : 274-279, 1995

      9 "Identification of polymorphic loci in the promoter re-gion of the serotonin 5-HT2C receptor gene and their asociation with obesity and type I diabetes" 43 : 373-376, 2000

      10 "Genetic variants of the serotonin system and weight change during clozapine treat-ment" 11 : 265-268, 2001

      11 "Evidence for a physiological re-gulation of food selection and nutrient intake in twins" 34 : 143-147, 1981

      12 "Evaluation of a Cys23Ser mutation within the hu-man 5-HT2C receptor gene: No evidence for an association of the mutant allele with obesity or underweight in childrenadoles-cents and young adults" 61 : 9-16, 1997

      13 "Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients" 37 : 193-220, 2003

      14 "Eating disorder and epilepsy in mice lacking 5-HT sub 2C serotonin receptors" 374 : 542-546, 1995

      15 "Clozapine-induced weight gain:Prevalence and clini-cal relevance" 149 : 68-72, 1992

      16 "Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study" 157 : 975-981, 2000

      17 "Clozapine treatment for suicidality in schizophrenia: International suicide prevention trial (InterSePT)" 60 : 82-91, 2003

      18 "Asociation of antipsycho-tic drug-induced weight gain with 5-HT2C receptor gene poly-morphism" 359 : 2086-2087, 2002

      19 "Asociation betwen the serotonin 2C re-ceptor gene and tardive dyskinesia in chronic schizophrenia:Ad-ditive contribution of 5-HT2CSer and DRD3Gly alleles to suscep-tibility" 152 : 408-413, 2000

      20 "Asociation betwen clozapine response and allelic varia-tion in the 5-HT2C receptor gene" 7 : 169-172, 1995

      21 "Antipsychotic-induced weight gain:A com-prehensive research synthesis" 156 : 1686-1696, 19

      22 "Adverse metabolic efects asociated with atypical antipsychotics:Literature review and clinical im-plications" 64 : 701-723, 2004

      23 "Adherence to antipsychotic medications" 60 (60): 25-30, 1999

      24 "A meta-analysis of the efficacy of second-generation antipsychotics" 60 : 553-564, 2003

      25 "A 5-HT2C receptor promoter polymorphism (HTR2C-759C/T) is associated with obesity in women and with resistance to weight loss in heterozygotesin" 126B : 124-127, 2004

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2019 평가예정 신규평가 신청대상 (신규평가)
      2018-12-01 평가 등재후보 탈락 (계속평가)
      2017-12-01 평가 등재후보로 하락 (계속평가) KCI등재후보
      2013-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2004-12-10 학술지명변경 외국어명 : 미등록 -> The Korean Journal of Psychopharmacology KCI등재후보
      2004-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2002-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.19 0.19 0.19
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.27 0.25 0 0
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼